ClinicalTrials.Veeva

Menu

Mapping the Human Colon Using Single Cell Sequencing (COLATA)

B

Bispebjerg Hospital

Status

Active, not recruiting

Conditions

Diabetes
Inflammatory Bowel Diseases
Large Bowel Cancer

Treatments

Diagnostic Test: Biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT05195502
COLKEND01

Details and patient eligibility

About

The overall purpose of this study is to describe the cellular composition of the human colon and its gene expression using scRNAseq and scATACseq methods. This will potentially provide is with a detailed map of the colon aiding our understanding of how diseases of the colon develop as well as the colons influence on systemic diseases such as type II diabetes.

Full description

The human colon is composed of four distinct histological layers: Serosa, muscularis externa, submucosa, and mucosa. The inner mucosal surface is composed of columnar epithelium and glandular tissue containing crypts of Lieberkühn and secretory goblet cells, lamina propria and muscularis mucosa. Several distinct cell types have been discovered in varying degree in the colon for example enteroendocrine cells and M-cells.

The cellular composition, patterns of gene expression and upstream regulatory pathways of the human colon varies across different anatomical location. This is evident in the anatomical bias in benign and malignant colorectal diseases. For example, the distal colon has a higher incidens of ulcerative colitis, diverticulitis, and chromosomal instability cancer whereas in the proximal colon ischemic colitis, collagenous colitis and microsatellite instability-induced cancer are predominant.

Currently there are no studies describing baseline data for genome-wide coding, methylation or gene expression related to specific anatomic locations in the human colon.

By using scRNAseq and scATACseq (Single-cell Assay of Transposase Accessible Chromatin sequencing) we will be able to map open regions in the cell's DNA and RNA, thus providing us with a unique "map" of the cells in the colon as well is their gene expression. ScATACseq visualizes open regions in the chromatin, generating "peaks" which can then be used to map DNA motifs, such as transcription factor binding sites. With the emergence of scATACseq, chromatin accessibility is in combination with gene expression data an extremely useful resource to study cell type specific regulatory DNA interactions. To further study the immunological aspects of the colon, we will extract immune cells from the colon. Lastly, full blood will be extracted to better analyze metabolic risk factors in relation to the colon's metabolic cellular regulation.

The overall purpose of this study is to describe the cellular composition of the human colon and its gene expression using scRNAseq and scATACseq methods. This will potentially provide is with a detailed map of the colon aiding our understanding of how diseases of the colon develop as well as the colons influence on systemic diseases such as type II diabetes.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients referred for out-patient colonoscopy as a result of positive hemoccult.
  • Patients able to read and understand danish.
  • Patients able to give informed consent.
  • Patients of Scandinavian ethnicity.

Exclusion criteria

  • Previous large bowel resections
  • Suspicion pre or intraoperatively of benign or malignant disease of the colon
  • Known inflammatory bowel disease.
  • Immuno-modulation treatment
  • Chemotherapy.
  • Daily smoking
  • > 21 weekly units of alcohol
  • < 18 years of age

Trial design

20 participants in 1 patient group

Screening colonoscopy patients
Description:
Patients referred for out-patient colonoscopy in the Danish Colorectal Screening program
Treatment:
Diagnostic Test: Biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems